Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes

Atre, Isha D; Watane, Gaurav V; Harisinghani, Mukesh G.

doi:10.1007/s00261-021-03231-4

Cited by 4 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The combination of CRS and HIPEC is found to extend survival to an average of 36 months [3,6,7,9,11]. Other treatments include a variety of chemotherapy and platinum agents and immunotherapy [1][2][3][4][5]8,[13][14][15]. At the time of our patient's radical resection, the diagnosis was unclear.…”

Section: Discussionmentioning

confidence: 99%

“…Malignant mesotheliomas are rare and aggressive tumors arising from serous linings of the pleura (65%-70%), peritoneum (30%), tunica vaginalis testis, and pericardium (1%-2%) [1]. Peritoneal mesothelioma (PM) was first described by Miller and Wynn in 1908 [2]. Histologically, PM is classified into three subtypes: epithelioid, sarcomatoid, and biphasic [2].…”

Section: Introductionmentioning

confidence: 99%

“…Peritoneal mesothelioma (PM) was first described by Miller and Wynn in 1908 [2]. Histologically, PM is classified into three subtypes: epithelioid, sarcomatoid, and biphasic [2]. A biphasic tumor is defined as having both epithelioid and sarcomatoid components [3].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity

Waheed¹,

Foroutan²,

McCloskey³

et al. 2022

Cureus

View full text Add to dashboard Cite

Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, "peritoneum." The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months.

show abstract